1-6 of 6
Anna Porwit, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Value of Flow Cytometry for MRD-Based Relapse Prediction in B-Cell Precursor Acute Lymphoblastic Leukemia in a Multi-Center Setting

Signe Modvig, MD PhD, Hans Madsen, Helene Hallböök, MD PhD, Sanna M. Siitonen, MD PhD, Liv T. N. Osnes, MD PhD, Susanne Rosthøj, PhD, Anne Tierens, MD PhD, Vesa Juvonen, PhD, Helen Vålerhaugen, Magnus Hultdin, MD PhD, Mats Ehinger, MD PhD, Anna Porwit, MD PhD, Reda Matuzeviciene, MD PhD, Mindaugas Stoskus, M Marincevic, PhD, Aili Lilleorg, PhD, Mervi Taskinen, MD PhD, Nina Toft, MD PhD, Ólafur Gísli Jónsson, MD PhD, Kaie Pruunsild, MD, Goda Elizabeta Vaitkeviciene, MD PhD, Kim Vettenranta, MD PhD, Bendik Lund, MD PhD, Jonas Abrahamsson, Kjeld Schmiegelow, Professor MD DMSc., Hanne Vibeke Marquart, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2755.
https://doi.org/10.1182/blood-2019-122311
Published: 2019
Journal Articles

Risk Factors for Acute Myeloid Leukemia and Myelodysplastic Syndromes in Patients with Multiple Myeloma: An Updated Analysis

Gudbjorg Jonsdottir, MD, Magnus Björkholm, MD PhD, Ingemar Turesson, MD PhD, Malin Hultcrantz, MD PhD, Anna Porwit, MD PhD, Yogesh Jethava, MBBS, MD FRCPath, MRCP, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4437.
https://doi.org/10.1182/blood-2018-99-111715
Published: 2018
Journal Articles

Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

Gudbjorg Jonsdottir, MD, Magnus Bjorkholm, MD PhD, Ingemar Turesson, MD PhD, Malin Hultcrantz, MD PhD, Anna Porwit, MD PhD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Ola Landgren, MD PhD, Sigurdur Y. Kristinsson, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4396.
https://doi.org/10.1182/blood.V130.Suppl_1.4396.4396
Published: 2017
Journal Articles

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Gudbjorg Jonsdottir, MD, Sigrún H. Lund, PhD, Magnus Björkholm, MD, PhD, Ingemar Turesson, MD, PhD, Anders Wahlin, MD, Prof., Malin Hultcrantz, MD, PhD, Anna Porwit, MD, PhD, Ola Landgren, MD, PhD, Sigurdur Y Kristinsson, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 3246.
https://doi.org/10.1182/blood.V128.22.3246.3246
Published: 2016
Journal Articles

Interlaboratory Validation of a 3-Tube 10-Color Antibody Flow Cytometry Panel for Diagnosis of Myelodysplastic Syndromes

Wolfgang Kern, MD, Marie-Christine Béné, PhD, Anna Porwit, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4941.
https://doi.org/10.1182/blood.V120.21.4941.4941
Published: 2012
Journal Articles

Evaluation of Azacitidine in Transfusion-Dependent, Epo-Refractory Patients with Lower-Risk Myelodysplastic Syndrome,

Magnus Tobiasson, MD, Lena Brandefors, MD, Ingunn Dybedal, MD, PhD, Hege Garelius, MD, Michael Grövdal, MD, PhD, Inge Hoegh Dufva, MD, PhD, Lars Kjeldsen, MD, PhD, Lars Nilsson, MD, PhD, Astrid Olsnes Kittang, MD, PhD, Anna Porwit, MD, PhD, Leonie Saft, MD, Mette Skov Holm, MD, PhD, Lars Möllgård, MD, Phd, Eva Hellström-Lindberg
Journal: Blood
Blood (2011) 118 (21): 3798.
https://doi.org/10.1182/blood.V118.21.3798.3798
Published: 2011